Schedule 13G ownership disclosure
CATALYST BIOSCIENCES, INC.
Security class unavailable · CUSIP: 14888D109
Event date: 2018-01-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-001450
- Form type
- SC 13G
- Filer
- GYRE THERAPEUTICS, INC.
- CIK
- CIK 1124105
- Filed
- Feb 05, 2018
- Reporting period
- Jan 26, 2018
- Description
- Schedule 13G beneficial ownership